Table 1.
Clinical and laboratory characteristics of the psoriatic patients and the controls
| Parameter | Psoriasis (n = 74) Median (Q1,Q3) |
Controls (n = 30) Median (Q1,Q3) |
p-value |
|---|---|---|---|
| Age (years) | 54.0 (41.0; 59.0) | 42.0 (38.0; 54.0) | NS |
| BMI (kg/m2) | 27.7 (23.89;33.09) | 23.81 (22.22; 26.02) | P = 0.001 |
| Men: Women | 49(66.2%):25(33.8%) | 20(67%):10(33%) | – |
| Psoriasis duration (months) | 17.0 (6.0; 30.0) | – | – |
| PASI score | 9.05 (5.9; 13.8) | – | – |
| Serum FABP5 concentration | 16.27 (12.42; 21.69) | 7.81 (6.33; 9.26) | P < 0.001 |
| Serum vitamin D concentration | 15.43 (11.16; 21.92) | 21.29 (16.38; 27.67) | NS |
Data shown as median and quartiles (Q1—first quartile; Q3—third quartile) and percentage. (BMI- body mass index, PASI – psoriasis area and severity index, NS – non-significant)